Kayexalate Enema Mixing Volume
For rectal administration of Kayexalate (sodium polystyrene sulfonate), mix 30-50 grams of the resin in 100-150 mL of aqueous vehicle, avoiding sorbitol-containing solutions due to severe gastrointestinal toxicity risk.
Dosing Specifications
The standard rectal dosing is 30-50 grams administered 1-2 times daily 111. While the guidelines specify the dose range, the typical mixing protocol involves:
- 30 grams in 100 mL of water or dextrose solution for standard administration
- 50 grams in 150 mL for higher doses
- The enema should be retained for 30-60 minutes if possible for optimal potassium binding in the distal colon
Critical Safety Considerations
Avoid sorbitol-containing preparations entirely. The combination of SPS with sorbitol has been directly implicated in catastrophic gastrointestinal complications including:
- Colonic necrosis with mortality rates up to 33% 11
- Intestinal ischemia and perforation 23
- Progressive necrosis affecting multiple GI segments 2
- Fatal outcomes occurring within days to weeks 24
The pathologic pattern is distinctive, with characteristic SPS crystals found in necrotic tissue, particularly in uremic patients 523. Uremia appears to be a major risk factor for this toxicity, making renal failure patients especially vulnerable 234.
Clinical Context and Alternatives
Given the serious safety profile, strongly consider newer potassium binders (patiromer or sodium zirconium cyclosilicate) as first-line alternatives 11. These agents have:
- No reported cases of fatal GI injury 11
- More predictable onset of action (7 hours for patiromer, 1 hour for SZC vs variable hours-to-days for SPS) 11
- Better safety profiles in clinical trials 1
SPS has minimal evidence supporting its use—only one small 7-day randomized trial exists 11—and its efficacy is inconsistent with highly variable onset of action 11.
Practical Administration Points
- Use water or dextrose solution only as the mixing vehicle
- Administer as a retention enema with patient in left lateral position
- Monitor for abdominal pain, rectal bleeding, or signs of bowel injury
- Avoid in patients with bowel obstruction, recent GI surgery, or inflammatory bowel disease
- Check serum potassium, calcium, and magnesium levels regularly due to nonselective binding 11
The high sodium content (1500 mg per 15-gram dose) 11 also warrants caution in volume-sensitive patients with heart failure or advanced kidney disease.